NITROPRESS Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Nitropress, and when can generic versions of Nitropress launch?
Nitropress is a drug marketed by Abbott, Abbvie, Hospira, and Vpna. and is included in four NDAs.
The generic ingredient in NITROPRESS is sodium nitroprusside. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the sodium nitroprusside profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nitropress
A generic version of NITROPRESS was approved as sodium nitroprusside by SAGENT PHARMS INC on December 8th, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NITROPRESS?
- What are the global sales for NITROPRESS?
- What is Average Wholesale Price for NITROPRESS?
Summary for NITROPRESS
| US Patents: | 0 |
| Applicants: | 4 |
| NDAs: | 4 |
| Raw Ingredient (Bulk) Api Vendors: | 11 |
| Clinical Trials: | 4 |
| Patent Applications: | 1,939 |
| Drug Prices: | Drug price information for NITROPRESS |
| DailyMed Link: | NITROPRESS at DailyMed |
Recent Clinical Trials for NITROPRESS
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| American Heart Association | Phase 2 |
| Massachusetts General Hospital | Phase 2 |
| Stanley Medical Research Institute | Phase 2 |
US Patents and Regulatory Information for NITROPRESS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott | NITROPRESS | sodium nitroprusside | INJECTABLE;INJECTION | 071555-001 | Nov 16, 1987 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Vpna | NITROPRESS | sodium nitroprusside | INJECTABLE;INJECTION | 071961-001 | Aug 1, 1988 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Abbvie | NITROPRESS | sodium nitroprusside | INJECTABLE;INJECTION | 018450-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Hospira | NITROPRESS | sodium nitroprusside | INJECTABLE;INJECTION | 070566-001 | Jun 9, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
